chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme headache, nausea, body aches and pains. Lasted 2-3 days
Pt recvd 3 doses of Engerix B & was determined to be a non responder. Pt recvd 2nd series of Engerix B & still did not respond.
Pt developed chills and uncontrollable shivering. A follow up report received 10/18/2001 adds: Reporter states pt had chills lasting several hours. Did not take temperature; went to bed and recovered with rest. No sequeale to this symptom.
After the first dose the patient noticed some numbness and "flashing" in the fingers of her left hand. She also had fever, chills and "rigors. Her left hand was painful and swollen. She saw her PCM and her medication dose was increased from 5mg to 10mg daily. However, her left hand remains discolored, swollen and bluish areas on her second and fifth digits. These areas have now become almost necrotic and she is being referred to VASCULAR for possible amputation.
100-degree fever for about 48 hours Congestion and sore throat for about 4 weeks Coughing for over 3 months
This spontaneous report as received from a nurse refers to a patient of unspecified demographics. On 07-JAN-2014, the patient was vaccinated with oral ROTATEQ suspension 2, dose and frequency reported as 2 ml one dose, (lot number h015715, expiry date 15-MAR-2014). Concomitant therapy was unspecified. On 18-MAR-2014, the patient was vaccinated with expired dose of oral ROTATEQ suspension 2, (lot # h015715, expiry date 15-MAR-2014). No adverse effect reported. No product quality complaint was involved. No further information was provided. Additional information has been requested.
Around January 10, 2022 I had very mild symptoms of COVID-19, but I tested negative for it. I felt tired and I had a little bit of a cough. My husband had some mild symptoms as well, and he tested positive for COVID-19. I believe I went to a local place in town where I got a false negative COVID-19 test. I just assumed that I had COVID-19 at that point. I felt better for about a week and then I felt tired. I had developed a fever. I decided to go to the walk-in clinic. They listened to my heart and ran an electrocardiogram. Then they sent me to the ER immediately. The doctors said I have myocarditis and then they hospitalized me. Then it gets blurry because I started to decline quickly. I ended up in the intensive care unit. They did a catheterization. My blood test kept showing very, very high levels of troponin. My heart went to 10% capacity. The doctors put an Impella heart device in me. They thought they would have to do a transplant or biopsy on me, but they wouldn't of have been able to do it there, so I was airlifted to another facility to get the transplant or biopsy if needed. I got to the second facility 6 days later. They didn't have to do a transplant or a heart biopsy. They said that it looked like my heart was fighting to keep beating. Then I kind of bounced back. Nobody knows why I bounced back so quickly. By January 2, 2022 I was released from the hospital. I wasn't able to move at all at first. I had to learn how to walk again. I went from a walker to a cane in the hospital. I am no longer using those anymore. I have a team of cardiologist that are walking with me. I go to cardio rehab 3x day. I was told that my femoral artery was damaged by the heart pump because it was not allowing blood and oxygen to flow to my leg properly. The last MRI shows no structural damage done to my heart. The doctors are wondering if the small blood vessels around the heart were damaged. Treating facility said that the heart device saved my life. They also said they know I had COVID-19 because it kept coming negative at first but then the test finally started showing up as positive. I was prescribed Lisinopril 2.5mg 1x day, Klor-Con M20 1x day, Metoprolol Succinate 12.5mg 1x day, Furosemide 20mg as needed, and Buspirone 5mg 3x day. The doctors told me to stop taking the birth control so I am no longer on it. I was hospitalized from January 20, 2022 to February 2, 2022 at both the first hospital and the second.
pt presented to clinic on 7/21 stating had fever off & on before vax on 7/12, states tremors noted and fever now; temp 102.3f axillary; treated for otitis media
Within 10 minutes of receiving COVID Vaccine dose #2, patient experience chest pressure, increased blood pressure and exacerbation of myasthenia gravis. Patient has a history of myasthenia gravis.
Information has been received from a 64 year old female registered nurse with no pertinent medical history and no drug reactions or allergies, who in approximately 1992 was vaccinated with a first and second dose of hepatitis A virus vaccine inactivated. Subsequently, the patient did not seroconvert for hepatitis A. The outcome is reported as not recovered. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Fever, the next morning a chickenpox-like rash developed on face, chest and back.
PERIPHERAL NEUROPATHY ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Body hives 5 and 9 days after the shot. On the scalp, hairline, right body, left body, inner thighs, and behind knees and back
This spontaneous report was received from a pharmacist refers to a 22 year old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date in December 2017, the patient was vaccinated with first dose of GARDASIL 9 (dose, units, route and frequency not reported) (lot# and expiration date unknown) and on an unknown date in June 2018, also reported as 6 months later (inappropriate schedule of drug administration), the patient vaccinated with second dose of GARDASIL 9) (dose, units, route and frequency not reported) (lot# and expiration date unknown). No adverse effects reported. No product quality complaint was involved.
Mother reported on 3/12 that 45 minutes after 3/8 rabies vaccine, child c/o chest hurting. Resolved without intervention 3 hours later.
My smart watch alerted me that I started going into A-fib, so I took half of my dose (pill) of Metoprolol (25mg) and was advised to go to the ER. My heart rate was over 150 when I got there, then it started getting back down to a normal range as the Metoprolol took effect.
Felt like throat was closing, EXTREMELY tired, nausea EXTREME HEADACHES for two nights, fever, chills, pain in left arm. Lasted for 3 days & nights. and after that I've had a mild headaches everyday . still pain in left arm
Right deltoid red and slightly swollen 2" diameter. Complained of knot at site.
I  requested the vaccine be given in 2 increments due to many adverse reactions to meds.  The pharmacist agree to do so.  After the first injection (.01 I think) things seemed fine after the 10 minute wait so we proceeded with the rest of the dose.  I waited the required 10 minutes.  As I was leaving the store I because nauseated and lightheaded.  I thought maybe I needed something to eat so bought myself 2 peaches and left the store.  ON the five minute drive to my house I started itching on my face, neck, and arms and only then did I realize I was having a reaction.  When I got home I looked in the mirror has had a rash on my face, neck, and arms.  (Should have taken a pic!!!).  It lasted about an hour and a half.  I told the pharmacy, she was not concerned and when I told her I probably should not take the second dose a month later she said that would be up to me.
Redness, soreness, swelling, and warmth at and around injection site. Onset of symptoms was within the first 24 hours. Area affected increased in size (approximate diameter of 3-4 inches) up to48 hours following vaccination. It is currently 72 hours following vaccination.
This spontaneous prospective pregnancy report as received from a pharmacist refers to a 25 years old female patient with no pertinent medical history and no drug allergies. On an unknown date in August 2012 (reported as sometime at the end of August 2012, which was four to five weeks before the patient became pregnant), the patient was vaccinated with a dose of M-M-R II (Lot number, expiry date and dose were not reported). Concomitant medications included: vitamins (unspecified) (Prenatal vitamins). Subsequently, the patient became pregnant (first pregnancy) with a last menstrual period (LMP) of 21-SEP-2012 and an estimated date of delivery (EDD) of 28-JUN-2013. The patient was exposed to M-M-R II during trimester 1 and 2. None of the laboratory test was performed. At the time of the report the patient was about 19 weeks pregnant. The patient sought medical attention (had called the reporting pharmacist). The outcome of pregnancy was unknown (outcome pending). Additional information is not expected.
Later that evening after receiving the immunizations, the patient reported chills and extremely sensitive and painful skin. The patient took ibuprofen before bed that night and the next day, her symptoms had subsided.
Patient reports developing rosacea/acne nodules that she claims follow along the dermatomes of her skin; is on her face and on her back.
THREE HOURS AFTER THE FIRST VACCINE WAS ADMINISTERED, THREE WELTS OF VARYING SIZES APPEARED  ON MY BACK. THE SKIN WAS BRIGHT RED AND IRRITATED.  THE WELTS WERE ACCOMPANIED BY EXTREME ITCHINESS.  THE ITCHINESS WAS ONLY EASED BY ICE PACKS AND LASTED FOUR DAYS.  CORTIZONE AND GOLD BOND WERE APPLIED TO EACH  WELT.  IT HAS BEEN SEVEN DAYS SINCE THE VACCINATION.  THE ITCHINESS HAS SUBSIDED BUT THE WELTS ARE STILL VISIBLE.
Initial report received from consumer on 26 Jul 2010: This patient received RABIPUR (batch number not reported) on an unknown date. The patient experienced vitreous hemorrhage in Jul 2010. The outcome was not reported. Following an internal review on 06 Aug 2010 of the information received on 26 Jul 2010, it was noted that following information was not entered previously: The patient was vaccinated with first dose of RABIPUR on 20 Jul 2010; with second dose on 07 Jul 2010; and with third dose on 30 Jul 2010, as pre-exposure series. Batch numbers were not reported. The first dose of vaccine was tolerated well. Late in the evening of 12 Jul 2010, the patient started to experiencing visual disturbances in the right eye described as a bar in front of eye. On the same night, the patient visited to a hospital, where the patient stayed overnight for completion of diagnostic tests. Visual field exam revealed important disturbances. Visual evoked potential (VEP) test was assessed as normal. The patient's mother described diagnosis as right-sided both vitreous hemorrhage and papilloedema consecutive to calcium deposit which was assessed likely related to hereditary factors by the hospital. The patient was given treatment with corticosteroids and anti-histaminic as peri-vaccination prophylaxis on 30 Jul 2010. The patient again visited hospital on 04 Aug 2010. The findings at visual field exam showed moderate improvement with normal VEP test and nearly complete resolution of vitreous hemorrhage on 04 Aug 2010. Papilloedema did not worsen but was still present, which was assessed as somewhat unusual. The patient was advised to return for control check-up examination in 2-3 months and was informed that the whole follow-up would involve at least 2 years.
PATIENT EXPERIENCE NUMBNESS AND HEAVINESS IN RIGHT EYE CAVITY THAT LASTED MORE THAN 15 MINUTES WHEN SHE REPORTED IT AND CONTINUED FOR AT LEAST 50 MINUTES
EMT noticed the client coughing as she walked into the restroom. The client returned from the restroom and reported feeling "hot and a headache" to EMT. The client ambulated and sat down in the anti-gravity chair. RNs responded. RN noticed the client sitting in the anti-gravity chair, leaning forward, with her eyes closed. The client reported "head pounding" and feeling "dizzy, like it's going around." The client localized the pain to the right side of her head, diffusely. Vitals obtained by EMT at 1:33 PM were as follows HR 102, automatic BP 206/90, and O2 96%. The client denied any history of hypertension. The client had acrylic nails and nail polish on all of her fingers. The client denied any s/s of anaphylaxis. The client reported a history of rheumatoid arthritis and takes calcor, vitamins, and iron daily. The client also reported a history of asthma and is prescribed an inhaler. The client reported that she receives an IV therapy treatment for her rheumatoid arthritis, and last received the medication two weeks ago. The client stated that the medication she received two weeks ago was a new treatment. The client stated her doctor recommended she receive the COVID vaccine Pfizer. The client has a history of face swelling and throat closing with Pregabalin. The client is not prescribed an Epi-Pen. The client stated that today she initially started feeling a dry throat, started coughing, walked to the bathroom, felt hot, and splashed water on her face. The client stated that she has previously experienced similar symptoms after taking a new medication and that the symptoms usually resolve after 30 minutes. Vitals obtained at 1:39PM were as follows: automatic BP 169/80, HR 91, and O2 95%. The client reported "my eyes are better." RN noted the client was holding her eyes open instead of closed. The client stated that she did eat today. The client localized the headache to the anterior right side of her head and near her right eye. The client denied any persistent dizziness. RN educated the client regarding her blood pressure and recommended she follow up with her PCP. RN  provided education regarding s/s of anaphylaxis. The client voiced understanding of this education. Vitals obtained at 1:54 PM were as follows: automatic BP 166/79, HR 91, O2 95%. The client reported a persistent "lingering headache" but stated that it was "manageable." The client's husband drove her to the vaccination site, and was planning on driving the client home. At 1:56 PM the client stood up unassisted and walked around the observation area.
Dizziness; Sore arm; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A.) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Dyslipidemia.    On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). On 30-Mar-2021, the patient experienced DIZZINESS (Dizziness). On 31-Mar-2021, PAIN IN EXTREMITY (Sore arm), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved. At the time of the report, DIZZINESS (Dizziness) had not resolved.            Concomitant medications included blood pressure and cholesterol medications. Treatment information included Tylenol.
My arm was really bruised and painful. About a month later, I began to develop a chronic cough. My doctor sent me for pulmonary testing a year later to see if I had asthma, which came back negative.
Pt was vaccinated on 06/27/1997 and on 12/24/04 came down with a rash diagnosed as chicken pox, reason for reporting is: several other pt's have chicken pox that have been vaccinated also but at different times.
provider realized that they had been treating Moderna vaccine as though it had preservative/ the vaccine was administered 11 days after initial puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (provider realized that they had been treating Moderna vaccine as though it had preservative/ the vaccine was administered 11 days after initial puncture) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (provider realized that they had been treating Moderna vaccine as though it had preservative/ the vaccine was administered 11 days after initial puncture). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (provider realized that they had been treating Moderna vaccine as though it had preservative/ the vaccine was administered 11 days after initial puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.   No treatment information was provided.   Reportedly, a provider realized that they had been treating Moderna vaccine as though it had preservative. A preliminary spreadsheet (with the affected doses administered, with the lot numbers and time from vial opening) was sent.   The patient in question received the vaccine  that was punctured 11 days earlier.   This case was linked to MOD-2021-332796, MOD-2021-332638.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up information was received include no new information.; Sender's Comments: This is a case of Expired product administered (Expired vaccine used) for this 54-year-old patient of an unknown gender. Reportedly, the patient received the vaccine that was punctured 11 days before administration which is considered to be Expired product administered. No adverse events were reported at this moment. The rechallenge is not applicable. The company causality is also assessed as not applicable. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
5 years old patient received 3rd dose of Daptacel 3 weeks too early with no reported adverse event; Initial information received on 05-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 5 years old female patient who received 3rd dose of diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel]  3 weeks too early with no reported adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s) and family history were not provided.   On 05-Apr-2023, the patient received 0.5 mL dose 3 of suspect diphtheria-15/tetanus/5 AC pertussis vaccine, suspension for injection (strength, - standard, frequency - once, lot - C5893AA, expiry date - 21-Jun-2023) via intramuscular route in the left arm for immunization, 3 weeks too early with no reported adverse event (inappropriate schedule of product administration) (latency: same day).   Reportedly, patient was supposed to receive the 3rd dose of Daptacel on 27Apr2023, but she received the third dose of Daptacel today (05Apr2023).  Action taken:  not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Currently - long COVID/ Covid test result=Positive; Currently - long COVID/ Covid test result=Positive; This is a spontaneous report received from a contactable reporter (consumer). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Mar2021 as dose 1, single (Lot number: IN6206), in left arm, on 18Apr2021 as dose 2, single (Lot number: EW0153), in left arm and on 10Nov2021 as dose 3 (booster), single (Lot number: FH8028) at the age of 44 years, in left arm for COVID-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications including Multivitamin. The following information was reported: VACCINATION FAILURE (medically significant), POST-ACUTE COVID-19 SYNDROME (medically significant) all with onset Jan2022, outcome "not recovered" and all described as "Currently - long COVID/ Covid test result=Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Jan2022) Positive. Clinical course: There were no other vaccines in four weeks and she did not have COVID prior to vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300029003 same patient and drug, different dose and event;
Extreme chills, shivering, fever 102, itching at shot site, swollen arm,  very tender and big swelling of lymph node in armpit.
4/14/03- received smallpox vaccine. 4/23/03- noticed shortness of breath at night, mild chest pain, lightheadedness alternating with chills and sweat. 4/25/03- all the above symptoms resolved without any intervention- patient went to ER concerned that his smallpox vaccine site looked "infected."- due to the elevated cardiac enzymes levels, he was admitted to ICU for observation- diagnosed with Myocarditis (lesion on his vaccinated site "normal.") 4/27/03- patient discharged in stable condition with decrease in cardiac enzymes levels Will mail patient's clinical summary via Fed-Ex.
its a little warm but no itching at the injection site; Red circle at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (its a little warm but no itching at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE WARMTH (its a little warm but no itching at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site). At the time of the report, VACCINATION SITE WARMTH (its a little warm but no itching at the injection site) and VACCINATION SITE ERYTHEMA (Red circle at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. The patient took no treatment.
Tingling in arm of vaccination. tingling in both legs. Shooting pain and tingling in both feet on First day. After that subsiding but still getting randomly.
About 10 minutes after the vaccine I began feeling dizzy.   I called the nurse over to my car.  She shared it was a side effect some people felt.  I stayed for about 50 minutes total and left as I did not feel an anaphylaxis response.  I then experienced vertigo that day and the next.  By the evening of the next day I felt the dizziness and vertigo relief.